Furthermore, Asia Pacific is expected to witness significant growth in the global memantine
market, owing to increasing focus of key players in manufacturing memantine tablets. For
instance, in October 2018, Dr. Reddy’s Laboratories launched memantine hydrochloride tablets
in the Indian market. They are available in 5mg and 10mg, equivalent to generic version of
Namenda tablets, which were already available in the U.S. market in July 2015.
Memantine Market– Competitive Analysis
Key players operating in the global memantine market include, Merz Pharmaceuticals, Lupin
Limited, Allergan plc. Novartis AG, Daiichi Sankyo Company, Limited, Ono Pharmaceutical Co
Ltd., Eisai Co., Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories, and Johnson & Johnson
Services, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com